A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier has partnered with Pfizer to supply five essential medications, including some that have been critical during the COVID-19 pandemic.
Premier data points to new shortages for supplies that play a vital role in COVID-19 testing, diagnostics and treatment.
According our new analysis, the cost to treat a COVID-19 patient who is mechanically ventilated is more than 5X higher than a COVID-19 patient who...
We analyzed the inpatient costs of COVID-19 care and compared the costs of treating patients with and without mechanical ventilation.
ProvideGx has partnered with Baxter Healthcare to supply pre-filled, single-use IV bags of dexmedetomidine hydrochloride.
Premier’s ProvideGx® program provides the access, security and availability of the generic drugs hospitals and clinicians on the front line need to treat their patients...
This drug category lacks competition, which can make it vulnerable to price increases and potential shortages.
Premier has been largely able to meet historical medical supply demand levels, as well as a significant proportion of surge demand.
This new partnership secures supply of amiodarone and sterile water, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care.
Premier releases annual report on its national drug shortage programs, which represent nearly 1,600 member hospitals.
Premier Inc., through its ProvideGx™ program, has partnered with Pfizer Inc. to supply Corvert® (ibutilide fumarate injection) and Vincristine Sulfate Injection, USP, to healthcare providers.
Despite the current drug shortages, ProvideGx has found a way to deliver the critical drugs pharmacists and clinicians need to serve their patients.
Through its ProvideGx™ program, Premier has partnered with Amphastar Pharmaceuticals, Inc. to supply to healthcare providers phytonadione injection and emergency, pre-filled syringes.
Premier's ProvideGx™ program and its partnership with Exela Pharma Sciences has successfully resolved the multi-year, national shortage of cysteine hydrochloride injection.
Healthcare Purchasing News | ProvideGx announces it will supply sodium bicarbonate injections to healthcare providers.
ProvideGx is now supplying cysteine hydrochloride injection to providers, a critical drug for pediatric and adult patients that require total parenteral nutrition.
Becker's Hospital Review | ProvideGx is now supplying cysteine hydrochloride injections.
Modern Healthcare | Premier subsidiary ProvideGx is now supplying cysteine hydrochloride injections to its member providers.
Modern Healthcare | Premier is working with drugmaker Fresenius Kabi to mitigate drug shortages of five injectables.
Strategic partnership brings a new source of supply to providers, innovating to alleviate the two-year shortage of metoprolol injection.